FDA Drugs recall ·
Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL)… recall
- Recall number
- D-0008-2026
- Date
- (initiated September 26, 2025)
- Company / brand
- Dr. Reddy's Laboratories, Inc.
600 College Rd E Ste 4000, Princeton, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 571 vials
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25
Why was it recalled?
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot # K250048
Distribution
Nationwide within the USA.
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0008-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.